High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi

Abstract Plasma Epstein‐Barr virus (EBV) DNA measurement has established prognostic utility in EBV‐driven lymphomas, where it serves as a circulating tumor DNA marker. The value of plasma EBV measurement may be amplified in sub‐Saharan Africa (SSA), where advanced imaging and molecular technologies...

Full description

Bibliographic Details
Main Authors: Nathan D. Montgomery, Cara Randall, Matthew Painschab, Ryan Seguin, Bongani Kaimila, Edwards Kasonkanji, Takondwa Zuze, Robert Krysiak, Marcia K. Sanders, Avian Elliott, Melissa B. Miller, Coxcilly Kampani, Fred Chimzimu, Maurice Mulenga, Blossom Damania, Tamiwe Tomoka, Yuri Fedoriw, Dirk P. Dittmer, Satish Gopal
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Cancer Medicine
Subjects:
diffuse large B‐cell lymphoma
Epstein‐Barr virus
HIV
prognosis
sub‐Saharan Africa
Online Access:https://doi.org/10.1002/cam4.2710

Internet

https://doi.org/10.1002/cam4.2710

Similar Items